Efficacy of AAV8-hUGT1A1 with Rapamycin in neonatal, suckling, and juvenile rats to model treatment in pediatric CNs patients

A clinical trial using adeno-associated virus serotype 8 (AAV8)-human uridine diphosphate glucuronosyltransferase 1A1 (hUGT1A1) to treat inherited severe unconjugated hyperbilirubinemia (Crigler-Najjar syndrome) is ongoing, but preclinical data suggest that long-term efficacy in children is impaired...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Xiaoxia, Aronson, Sem J., ten Bloemendaal, Lysbeth, Duijst, Suzanne, Bakker, Robert S., de Waart, Dirk R., Bortolussi, Giulia, Collaud, Fanny, Oude Elferink, Ronald P., Muro, Andrés F., Mingozzi, Federico, Ronzitti, Giuseppe, Bosma, Piter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809245/
https://www.ncbi.nlm.nih.gov/pubmed/33511243
http://dx.doi.org/10.1016/j.omtm.2020.11.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809245/
https://www.ncbi.nlm.nih.gov/pubmed/33511243
http://dx.doi.org/10.1016/j.omtm.2020.11.016

Ejemplares similares